The Boehringer Ingelheim has interest in well being that matches CCD’s mission and history. The 1st partner can bring finance, expertise/ connections while the 2nd can execute the ideas, reach to local stakeholders, influence policy (education, healthcare, horticulture etc.). Hence, it can by symbiotic relationship. The German partner can also bring in European/ global experience in the topic. Neutraceutical is a rapidly growing business where the proposal is aimed so it suits both.
Research and Development, Relationships/New Contacts, Marketing/Communications Support, Access to Capital.
We need research & development for scientific validation of our ideas, by consulting experts, physicians, produce education material- digital broadcasting. We need some laboratory test (rental) for safety & efficacy tests. We need new contacts, relations for this & access to capital. Marketing-communication support is most desired as we have limited experience in it. We are not product manufacturers so need no factory, technology or distribution channels or legal/ policy expertise/ human resources.
Deep understanding of an unmet need in a specific market/context, Access to and established trust with customers/beneficiaries, Insights into pricing and financing of health products/services, Insights into marketing.
Improving the affordability of healthcare (e.g., microinsurance, reducing the economic cost of care), Increasing physical access to healthcare to people with restricted mobility or restricted access (senior people, people with disability, remote or difficult areas, etc.), Holistic solutions that work across the entire care continuum (including education, prevention, detection, treatment, management, follow-up), Models that engage other industry players (e.g., nutrition, athletic, mobility organizations)., Remote care solutions for health management, treatment, and diagnosis, Packaging of health products and services to address needs currently unmet.